Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) EBT (2016 - 2025)

Orthopediatrics has reported EBT over the past 10 years, most recently at -$9.8 million for Q4 2025.

  • Quarterly results put EBT at -$9.8 million for Q4 2025, up 40.5% from a year ago — trailing twelve months through Dec 2025 was -$39.2 million (up 6.54% YoY), and the annual figure for FY2025 was -$39.2 million, up 6.54%.
  • EBT for Q4 2025 was -$9.8 million at Orthopediatrics, up from -$11.9 million in the prior quarter.
  • Over the last five years, EBT for KIDS hit a ceiling of $14.4 million in Q3 2022 and a floor of -$16.4 million in Q4 2024.
  • Median EBT over the past 5 years was -$7.2 million (2023), compared with a mean of -$6.2 million.
  • Peak annual rise in EBT hit 678.38% in 2022, while the deepest fall reached 4656.63% in 2022.
  • Orthopediatrics' EBT stood at -$166000.0 in 2021, then tumbled by 4656.63% to -$7.9 million in 2022, then grew by 12.58% to -$6.9 million in 2023, then crashed by 137.71% to -$16.4 million in 2024, then surged by 40.5% to -$9.8 million in 2025.
  • The last three reported values for EBT were -$9.8 million (Q4 2025), -$11.9 million (Q3 2025), and -$7.1 million (Q2 2025) per Business Quant data.